Total Payments
$746.23
2024 Payments
$245.72
Companies
6
Transactions
18
Medicare Patients
13,611
Medicare Billing
$917,425
Payment Breakdown by Category
Food & Beverage$746.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.23 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $421.04 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $123.91 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $87.95 | 4 | $0 (2020) |
| Edwards Lifesciences Corporation | $64.33 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $34.60 | 2 | $0 (2024) |
| ATRICURE, INC. | $14.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.72 | 5 | Abbott Laboratories ($172.44) |
| 2023 | $155.90 | 3 | Abbott Laboratories ($137.74) |
| 2022 | $110.86 | 1 | Abbott Laboratories ($110.86) |
| 2020 | $43.51 | 2 | Edwards Lifesciences Corporation ($21.89) |
| 2019 | $25.21 | 1 | Novartis Pharmaceuticals Corporation ($25.21) |
| 2018 | $110.00 | 3 | Merck Sharp & Dohme Corporation ($110.00) |
| 2017 | $55.03 | 3 | Novartis Pharmaceuticals Corporation ($41.12) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $42.44 | General |
| 07/08/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $141.75 | General |
| Category: Heart Failure | ||||||
| 03/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Cardiovascular | ||||||
| 01/17/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Heart Failure | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Cardiovascular | ||||||
| 10/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: Heart Failure | ||||||
| 05/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $134.26 | General |
| Category: Heart Failure | ||||||
| 03/21/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $110.86 | General |
| Category: Heart Failure | ||||||
| 03/09/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 02/19/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 10/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,480 | 4,416 | $704,571 | $237,906 |
| 2022 | 33 | 3,590 | 4,700 | $709,022 | $237,356 |
| 2021 | 35 | 3,450 | 4,617 | $660,863 | $238,797 |
| 2020 | 36 | 3,091 | 3,742 | $596,135 | $203,367 |
Total Patients
13,611
Total Services
17,475
Medicare Billing
$917,425
Procedure Codes
181
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 5 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2021 | 44 | 205 | $15,735 | $5,549 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 74 | $17,070 | $4,840 | 28.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 25 | 97 | $10,864 | $4,615 | 42.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $11,658 | $4,541 | 39.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 30 | 51 | $8,096 | $4,412 | 54.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 36 | $9,756 | $3,834 | 39.3% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2021 | 44 | 205 | $12,095 | $3,808 | 31.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 44 | $11,176 | $3,622 | 32.4% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2021 | 36 | 36 | $8,640 | $3,081 | 35.7% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 37 | 37 | $8,510 | $2,845 | 33.4% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2021 | 99 | 99 | $8,910 | $2,778 | 31.2% |
| 93264 | Remote monitoring of wireless pressure sensor in lung artery with qualified health care professional analysis, review, and report | Office | 2021 | 13 | 52 | $5,252 | $1,992 | 37.9% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 153 | 153 | $5,049 | $1,725 | 34.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2021 | 19 | 19 | $7,752 | $1,628 | 21.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 20 | $3,031 | $1,360 | 44.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 75 | 75 | $3,750 | $1,146 | 30.6% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 51 | 52 | $3,068 | $972.34 | 31.7% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 55 | 55 | $2,750 | $889.22 | 32.3% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2021 | 16 | 16 | $2,560 | $845.68 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $2,933 | $838.30 | 28.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2021 | 57 | 58 | $1,914 | $667.30 | 34.9% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2021 | 31 | 31 | $2,821 | $660.48 | 23.4% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Facility | 2021 | 22 | 22 | $1,958 | $651.59 | 33.3% |
| 93975 | Ultrasound scan of abdominal, pelvic, and/or scrotal arterial inflow and venous outflow | Facility | 2021 | 16 | 16 | $2,528 | $624.60 | 24.7% |
| 93321 | Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers | Facility | 2021 | 72 | 72 | $3,552 | $378.27 | 10.6% |
About Dr. Lance Richards, DO
Dr. Lance Richards, DO is a Internal Medicine healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396908901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Richards, DO has received a total of $746.23 in payments from pharmaceutical and medical device companies, with $245.72 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($746.23).
As a Medicare-enrolled provider, Richards has provided services to 13,611 Medicare beneficiaries, totaling 17,475 services with total Medicare billing of $917,425. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Fort Collins, CO
- Active Since 07/03/2008
- Last Updated 12/26/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396908901
Products in Payments
- CARDIOMEMS (Device) $421.04
- MK-1242 (Drug) $110.00
- ENTRESTO (Drug) $87.95
- ELIQUIS (Drug) $18.16
- CAMZYOS (Drug) $16.44
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $14.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Collins
Steven Schuster, M.d, M.D
Internal Medicine — Payments: $347,736
Internal Medicine $347,736
Dr. Justin Strote, M.d, M.D
Internal Medicine — Payments: $65,289
Internal Medicine $65,289
Jason Mayer, M.d, M.D
Internal Medicine — Payments: $41,797
Internal Medicine $41,797
Russell Heath, Md, MD
Internal Medicine — Payments: $9,459
Internal Medicine $9,459
Allison Schneider, D.o, D.O
Internal Medicine — Payments: $6,736
Internal Medicine $6,736
Dr. Alejandro Munoz, M.d, M.D
Internal Medicine — Payments: $6,564
Internal Medicine $6,564